

HY-16350 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-16350
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bold-100.html
Description
BOLD-100 NKP-1339; IT-139 is the first-in-class ruthenium-based anticancer agent in development against solid cancer with limited side effects. BOLD-100 induces G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway. BOLD-100 has a high tumor targeting potential, strongly binds to serum proteins such as albumin and transferrin and activates in the reductive tumor milieu.







